Events

Research and Innovation Symposium for European Security and Defence 2023
MAY
Mon
29
MAY
Tue
30
MAY
Wed
31

This was 2 years ago

Location

Rhodes, Greece

Iraklidon Avenue (Trianton), Ixia, 85100 Rhodes, Greece
Programmes
Security

Satways, Information Technologies Institute and the Bulgarian Defence Institute are organising the Research and Innovation Symposium for European Security and Defence 2023 (RISE-SD 2023) with the participation and support of the European Commission (DG HOME, CERIS, JRC, DRMKC, REA) and the European Cluster for Securing Critical Infrastructures.

RISE-SD 2023 is an international event situated within the European R&D communities in Civil Protection & Defence. Its main topics concern:

  • Civil protection and disaster-resilient societies
  • Critical infrastructures Resilience and smart cities
  • Protection regarding crime and terrorrism
  • Protection of public spaces
  • EU external border management
  • EU Defence capability enhancements
  • Cybersecurity
  • Security R&I

Panel sessions include the presentation of H2020 project results, live demonstrations of technical solutions and high-level speakers.

This year's edition will take place in Rhodes, Greece. You can find more information on the official website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.